Ras Proteins News and Research

RSS

Scientists discover how sugar fuels cancer growth

A nine-year research project looking at the link between sugar and cancer has led to an important breakthrough in cancer research.

17 Oct 2017

Breakthrough discovery reveals positive correlation between sugar and cancer

A nine-year joint research project conducted by VIB, KU Leuven and VUB has led to a crucial breakthrough in cancer research.

13 Oct 2017

Scientists identify RIOK1 enzyme as new target for cancer therapy

Dr. Florian Weinberg, from Prof. Dr. Tilman Brummer's research group at the Institute of Molecular Medicine and Cell Research of the University of Freiburg, joined forces with scientists from the Departments of Clinical Pathology and Medicine I of the University Medical Centre Freiburg and the Kinghorn Cancer Centre/Garvan Insitute in Australia in an international team that has identified a new target for cancer therapy.

5 May 2017

Cancer Research UK, CRT Pioneer Fund, and NCI join forces to tackle ‘undruggable’ RAS mutations

Cancer Research UK and the Cancer Research Technology Pioneer Fund have committed £2.5 million in collaboration with the National Cancer Institute in the US to tackle one of the toughest challenges in cancer that has thwarted researchers for more than 30 years.

21 Apr 2017

Supercomputers reveal how cell membranes control shape and function of cancer-causing protein

Two biophysicists from Case Western Reserve University School of Medicine have used supercomputers to show how cell membranes control the shape, and consequently the function, of a major cancer-causing protein.

4 Apr 2017

Scientists identify new way to block action of genetic mutations found in most cancers

Researchers at the University of Illinois at Chicago have identified a new way to block the action of genetic mutations found in nearly 30 percent of all cancers.

7 Nov 2016

Cutting off fuel to cancer cells may be potential therapeutic strategy for Kras-driven lung cancers

Research from investigators at Rutgers Cancer Institute of New Jersey and Princeton University has identified a new approach to cancer therapy in cutting off a cancer cell's 'fuel supply' by targeting a cellular survival mechanism known as autophagy.

11 Aug 2016

Discovery may open new doors to understanding how melanoma grows and spreads

Of the hundreds of genes that can be mutated in a single case of melanoma, only a handful may be true "drivers" of cancer. In research that recently appeared in Nature Genetics, a Weizmann Institute of Science team has now revealed one of the drivers of a particularly deadly subset of melanomas that is seeing a rise in new cases.

27 Oct 2015

UCSF researchers lead $10 million research project on pediatric cancer

Researchers at UC San Francisco are leading a five-year, $10 million research project dedicated to pediatric cancer, funded by the first grant of its kind to focus on a molecular pathway that underlies many cancers rather than on a cancer in a particular organ or tissue in the body.

9 Sep 2015

BeyondSpring files two patent applications to expand therapeutic scope of Plinabulin

BeyondSpring Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, today announced that it has filed two new method of treatment patent applications with the United States Patent and Trademark Office to cover methods of treating brain tumors as well as cancers expressing a mutant form of RAS protein through administration of the Company’s lead compound, Plinabulin.

26 Mar 2015

RUB biochemists gain new insights into generation, maintenance of circadian rhythms

Biochemists at the Ruhr-Universität Bochum have gained new insights into the generation and maintenance of circadian rhythms. They demonstrated that the Ras protein is important for setting the phase of such a circadian clock, as its activity determines the period length of the rhythm.

19 Mar 2015

Combination therapies may overcome resistance to targeted cancer drugs

A protein called YAP, which drives the growth of organs during development and regulates their size in adulthood, plays a key role in the emergence of resistance to targeted cancer therapies, according to a new study led by UC San Francisco researchers.

10 Feb 2015

Ras Proteins News and Research

Scientists discover how sugar fuels cancer growth

Breakthrough discovery reveals positive correlation between sugar and cancer

Scientists identify RIOK1 enzyme as new target for cancer therapy

Cancer Research UK, CRT Pioneer Fund, and NCI join forces to tackle ‘undruggable’ RAS mutations

Supercomputers reveal how cell membranes control shape and function of cancer-causing protein

Scientists identify new way to block action of genetic mutations found in most cancers

Cutting off fuel to cancer cells may be potential therapeutic strategy for Kras-driven lung cancers

Discovery may open new doors to understanding how melanoma grows and spreads

UCSF researchers lead $10 million research project on pediatric cancer

BeyondSpring files two patent applications to expand therapeutic scope of Plinabulin

RUB biochemists gain new insights into generation, maintenance of circadian rhythms

Combination therapies may overcome resistance to targeted cancer drugs

Scientists find possible way to halt a common fault in different cancers

Researchers find molecule that irreversibly interferes with activity of mutated cancer gene

Cancer researchers find molecule that irreversibly interferes with KRAS gene

Researchers unlock secret behind the activation of Ras proteins

Clusters of protein linked to cancer warp cell membranes

Deciphera Pharmaceuticals initiates Phase 1 clinical trial of pan-RAF inhibitor LY3009120

Researchers find biological weakness in the workings of mutated gene involved in human cancers

Scientists explain new family of proteins that appear to play key role in cancer

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News